Group 1 winning filly Yankee Rose has been disqualified from her second placing in the Group 1 $500,000 Sydney Airport Flight Stakes (1600m) at Randwick on October 1 after returning a positive swab.
The banned anti-inflammatory drug Ketorolac was detected in a urine sample after Yankee Rose was runner up to the Gai Waterhouse and Adrian Bott trained Global Glamour in the Group 1 for the fillies.
As well as disqualifying Yankee Rose at today’s inquiry, Racing New South Wales Stewards fined trainer David Vandyke $25,000 after he pleaded guilty to allowing the substance to be administered to Yankee Rose and presenting the filly on race day with a banned drug in her system.
Veterinarian David Garth was also fined $15,000 for administering the drug.
Yankee Rose was sent out as the $2.05 favourite for the Flight Stakes but was unable to haul in the leader Global Glamour who started at the good odds of $6 and the $99,000 she collected for second placing will have to be forfeited by her connections.
The rest of the six horse field will be promoted one spot with the Chris Waller trained Sezanne moving to second and Skylight Glow from the James Cummings stable moves up to third.
Darby Racing, who put together a syndicate of about twenty owners to race Yankee Rose, tweeted that they were very disappointed with the outcome of today’s inquiry.
“Extremely disappointed with outcome re Yankee Rose Enquiry disq. her 2nd in the G1 Flight Stakes due to a NON-steroidal anti-inflam positive,” Darby Racing tweeted.
Yankee Rose is a winner of four of her nine race starts and include victories in the Group 1 $1m Inglis Sires’ (1400m) at Randwick during the 2016 Sydney Autumn Carnival and in the Group 1 $500,000 Moet & Chandon Spring Champion Stakes (2000m) at Randwick during the Spring.
The All American filly also ran third behind Winx and Hartnell in the Group 1 $3m Cox Plate (2040m) at Moonee Valley during the 2016 Melbourne Spring Carnival.